В работе освещаются основные вопросы патогенеза акне, в частности поздних акне (acne tarda), место топической антибиотикотерапии в комплексном лечении акне. Описана эффективность клиндамицина на примере разных исследований. Приведены примеры адекватного назначения геля клиндамицина в разных клинических случаях.
________________________________________________
The work describes the main issues the pathogenesis of acne, in particular late-onset acne (acne tarda), topical antibiotic therapy in the complex treatment of acne. Described the effectiveness of clindamycin in the different studies. The examples adequately purpose of clindamycin gel in different clinical situations.
1. Bhate K, William, HC. Epidemiology of acne vulgaris. Br J Dermatol 2013; 168: 474–85.
2. Vexiau P et al. Acne in adult women: data from a national study on the relationship between type of acne and markers of clinical hyperandrogenism. Ann Dermato. Venerol 2002; 129 (2): 174.
3. Seirafi H, Farnaghi F, Vasheghani-Farahani A et al. Assessment of androgens in women with adult-onset acne. Int J Dermatol 2007; 46: 1188–91.
4. Thiboutot D. Overview of acne and its treatment. Cutis 2008; 81 (S1): 3–7.
5. Clarke S, Nelson A, George R et al. Pharmacologic modulation of sebaceous gland activity: Mechanisms and clinical applications. Dermatol Clin 2007; 25: 137–46.
6. Haider A, Shaw JC. Treatment of acne vulgaris. JAMA 2004; 292 (6): 726–35.
7. Rivera R, Guerra A. Management of acne in women over 25 years of age. Actas Dermosifiliogr 2009; 100: 33–7.
8. Williams C, Layton AM. Persistent acne in women: implications for the patient and for therapy. Am J Clin Dermatol 2006; 7: 281–90.
9. Leyden JJ, Hickman JG, Jarratt MT et al. The efficacy and safety of a combination benzoyl peroxide/clindamycin topical gel compared with benzoyl peroxide alone and a benzoyl peroxide/erythromycin combination product. J Cutan Med Surg 2001; 5: 37–42.
10. Gollnick H, Cunliffe W, Berson D et al. Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol 2003; 49 (Suppl. 1): S1–37.
11. Eady EA, Cove JH, Layton AM. Is antibiotic resistance in cutaneous propionibacteria clinically relevant? Implications of resistance for acne patients and prescribers. Am J Clin Dermatol 2003; 4: 813–31.
12. Инструкция по применению препарата Далацин, [электронный ресурс], URL http://www.rlsnet.ru/tn_index_id_1123.htm#beforefv, дата обращения 05.09.2016.
13. Becker L.C. et al. Final report of the safety assessment of allantoin and its related complexes. Int. J. Toxicol. 2010; 29: 4–97.
Авторы
О.О.Мельниченко1, Л.Р.Сакания2, Ю.В.Семенова3, И.М.Корсунская*2
1. ГБУЗ Московский научно-практический центр дерматовенерологии и косметологии Департамента здравоохранения г. Москвы. 119071, Россия, Москва, Ленинский пр-т, д. 17;
2. ФГБУН Центр теоретических проблем физико-химической фармакологии. Филиал «Клиника В.Г.Короленко». 119991, Россия, Москва, Ленинский пр-т, д. 38а, корп. 1;
3. ФГАОУ ВО Российский университет дружбы народов. 117198, Россия, Москва, ул. Миклухо-Маклая, д. 8, корп. 1
*marykor@bk.ru
________________________________________________
O.O.Melnichenko1, L.R.Sakaniya2, Yu.V.Semenova3, I.M.Korsunskaya*2
1. Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology of the Department of Health of Moscow. 119071, Russian Federation, Moscow, Leninskiy pr-t, d. 17;
2. Center for Theoretical Problems of Physicochemical Pharmacology. Branch office "Clinic V.G.Korolenko". 119991, Russian Federation, Moscow, Leninskiy pr-t, d. 38a;
3. People’s Friendship University of Russia. 117198, Russian Federation, Moscow, ul. Miklukho-Maklaia, d. 8, korp. 1
*marykor@bk.ru